Fingerprint
Dive into the research topics of 'Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease
Martinus A. Cozijnsen, Johanna C. Escher, Anne Griffiths, Dan Turner, Lissy De Ridder*
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
20
Scopus
citations